Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NLS-2 OLE in Narcolepsy
NCT05055024Phase 2Completed
- Sponsor
- NLS Pharmaceutics AG
- Start
- Oct 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mazindol ER in narcolepsy, sponsored by NLS Pharmaceutics AG. Started Oct 2021; status: completed.
02
Drugs
Mazindol ER
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT05055024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05055024.